Clinical Trial Update: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of varenicline versus placebo and bupropion (Zyban) for smoking cessation completed over a 12-week period.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Varenicline (varenicline)
• Zyban (bupropion)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED